DeepMed Research

Bausch & Lomb Incorporated

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1992-10-08

Employees: -

Market Cap: -

Website

Clinical Trials

Insertion Clinical Study to Evaluate the Aberration Characteristics of Kalifilcon A Toric Lenses

Not Applicable

Completed

Conditions: Contact Lens Wearer

Interventions: Device: kalifilcon A Daily Disposable Toric LD213001 lens in SKUs +6D, +3D, 0D, -3D, -6D, and -9D

First Posted Date: 2021-11-22

Last Posted Date: 2021-11-22

Lead Sponsor: Bausch & Lomb Incorporated

Target Recruit Count: 180

Registration Number: NCT05129072

Locations: 🇺🇸
Bausch and Lomb Site 01, Rochester, New York, United States

2-Hour Dispensing Evaluation of Samfilcon A Lenses With EPG01 Packaging Solution Compared to Commercially Available B+L Ultra Lenses

Not Applicable

Completed

Conditions: Contact Lens Wearer

Interventions: Device: samfilcon A Lenses with EPG01 Packaging Solution
Device: B+L Ultra Lenses

First Posted Date: 2021-11-19

Last Posted Date: 2021-11-19

Lead Sponsor: Bausch & Lomb Incorporated

Target Recruit Count: 30

Registration Number: NCT05126953

Locations: 🇺🇸
Bausch and Lomb Site 01, Rochester, New York, United States

Retrospective Chart Review of enVista Toric 0.9D Intraocular Lenses

Completed

Conditions: Corneal Astigmatism

Interventions: Device: enVista non-Toric (spherical)
Device: enVista Toric

First Posted Date: 2021-10-13

Last Posted Date: 2024-03-27

Lead Sponsor: Bausch & Lomb Incorporated

Target Recruit Count: 302

Registration Number: NCT05075746

Locations: 🇨🇦
Bausch Site 03, Langley, British Columbia, Canada
🇨🇦
Bausch Site 02, Toronto, Ontario, Canada
🇨🇦
Bausch Site 01, Calgary, Alberta, Canada

Product Performance of a New Silicone Hydrogel Contact Lens

Not Applicable

Completed

Conditions: Myopia

Interventions: Device: kalifilcon A
Device: delefilcon A
Device: senofilcon A

First Posted Date: 2021-05-26

Last Posted Date: 2021-07-08

Lead Sponsor: Bausch & Lomb Incorporated

Target Recruit Count: 805

Registration Number: NCT04901897

Locations: 🇺🇸
Bausch Site 431, Scottsdale, Arizona, United States
🇺🇸
Bausch Site 406, Azusa, California, United States
🇺🇸
Bausch Site 430, Los Angeles, California, United States

and more 32 locations

Surface Refractive Index Shift and Lens Absorption/Adsorption of Tear Components of Kalifilcon A Lenses vs Dailies Total1 and Precision1

Not Applicable

Completed

Conditions: Habitual Soft Contact Lens Use

Interventions: Device: Kalifon A
Device: Precision1
Device: Dailies Total1

First Posted Date: 2021-04-12

Last Posted Date: 2021-07-22

Lead Sponsor: Bausch & Lomb Incorporated

Target Recruit Count: 10

Registration Number: NCT04840563

Locations: 🇺🇸
Bausch Site 001, Rochester, New York, United States

Safety and Efficacy of a New Transepithelial Photorefractive Keratectomy Treatment

Not Applicable

Completed

Conditions: Ametropia

Interventions: Procedure: Standard Photorefractive keratectomy (PRK)
Procedure: Transepithelial Photorefractive keratectomy (tPRK) without laser polishing
Procedure: Transepithelial Photorefractive keratectomy (tPRK) with laser polishing

First Posted Date: 2021-01-06

Last Posted Date: 2022-10-07

Lead Sponsor: Bausch & Lomb Incorporated

Target Recruit Count: 39

Registration Number: NCT04698174

Locations: 🇵🇭
Asian Eye Institute, Makati City, Philippines

Safety and Efficacy of Different Add Powers With a New Presbyopic Lasik Treatment Algorithm

Not Applicable

Completed

Conditions: Ametropia

Interventions: Procedure: SUPRACOR Regular
Procedure: SUPRACOR Strong

First Posted Date: 2020-11-05

Last Posted Date: 2024-03-01

Lead Sponsor: Bausch & Lomb Incorporated

Target Recruit Count: 60

Registration Number: NCT04617080

Locations: 🇵🇭
Asian Eye Institute, Makati City, Philippines

Effect of NOV03 on Signs and Symptoms of Dry Eye Disease Associated With Meibomian Gland Dysfunction (Mojave Study)

Phase 3

Completed

Conditions: Dry Eye Disease

Interventions: Drug: NOV03
Drug: Saline Solution

First Posted Date: 2020-09-28

Last Posted Date: 2024-08-19

Lead Sponsor: Bausch & Lomb Incorporated

Target Recruit Count: 620

Registration Number: NCT04567329

Locations: 🇺🇸
Bausch Site 226, Murrieta, California, United States
🇺🇸
Bausch Site 202, Garden Grove, California, United States
🇺🇸
Bausch Site 220, Norfolk, Virginia, United States

and more 32 locations

Evaluation of Surface Refractive Index Shift of Kalifilcon A Lenses Compared to Dailies Total 1, Precision 1 and Biotrue ONEday Lenses

Not Applicable

Completed

Conditions: Habitual Soft Contact Lens Use

Interventions: Device: kalifilcon A lenses
Device: Dalies Total 1
Device: Precision 1
Device: Biotrue ONEday

First Posted Date: 2020-09-18

Last Posted Date: 2021-11-08

Lead Sponsor: Bausch & Lomb Incorporated

Target Recruit Count: 10

Registration Number: NCT04555031

Locations: 🇺🇸
Bausch and Lomb Site 01, Rochester, New York, United States

Clinical Study to Evaluate the Safety and Performance of the enVista® One-Piece Hydrophobic Acrylic Trifocal Intraocular Lens in Subjects Undergoing Cataract Extraction

Not Applicable

Completed

Conditions: Cataract

Interventions: Device: enVista MX60EFH trifocal intraocular lenses (IOLs)
Device: enVista MX60E monofocal intraocular lenses (IOLs)

First Posted Date: 2020-01-13

Last Posted Date: 2024-10-10

Lead Sponsor: Bausch & Lomb Incorporated

Target Recruit Count: 165

Registration Number: NCT04224155

Locations: 🇨🇦
Bausch Site 108, Vaughan, Ontario, Canada
🇨🇦
Bausch Site 104, Montréal, Quebec, Canada
🇨🇦
Bausch Site 106, Calgary, Alberta, Canada

and more 6 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy